Delivery Order SPE2DB25D2203-SPE2DB25FPSJB
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Fenofibrate 145 mg tablets (90-count packages) with a ceiling value of $59,272.53 and a firm fixed price structure. The contract is set to reach ultimate completion by September 17, 2025, and represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.17 to AmerisourceBergen Drug Corp for Fenofibric Acid DR 135 mg capsules (90-count supply) on June 2, 2025, with completion scheduled for June 3, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,885.87 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of 500 units of 145 mg Fenofibrate tablets to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $107,703.25, is for the delivery of Fenofibrate 145 mg tablets over the period ending on April 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,301.09, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through March 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,836.58, is for the delivery of Fenofibrate 145 mg tablets in quantities of 500 per bottle. The contract is a firm fixed-price delivery order with a period of performance through February 24, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $1,750.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 145 mg fenofibrate tablets. The order is for 100 tablets to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 4, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for a common cholesterol medication supports the Defense Logistics Agency's mission to provide critical healthcare...
- The Defense Logistics Agency awarded a $34,874.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 145 mg fenofibrate tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is July 7-10, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for a common cholesterol medication supports the Agency's mission to provide logistical support for all military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 48 mg tablets. The contract has a ceiling value of $1,713.70 and is a firm fixed price delivery order with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for the delivery of a wide...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSJBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,856.42 for Fenofibrate 40 mg tablets (90-count supply) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for federal military and veteran healthcare systems through its comprehensive IDC vehicle. This prime contract enables the company to supply a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current fenofibrate delivery order represents routine pharmaceutical procurement activity typical of the DLA's ongoing medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/19/25 |